Back to User profile » Dr Maria Gabriella Raimondo
Papers published by Dr Maria Gabriella Raimondo:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registry
Favalli EG, Becciolini A, Biggioggero M, Bertoldi I, Crotti C, Raimondo MG, Marchesoni A
Drug Design, Development and Therapy 2018, 12:1421-1429
Published Date: 24 May 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability
Becciolini A, Raimondo MG, Crotti C, Agape E, Biggioggero M, Favalli EG
Drug Design, Development and Therapy 2017, 11:1969-1978
Published Date: 28 June 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
Raimondo MG, Biggioggero M, Crotti C, Becciolini A, Favalli EG
Drug Design, Development and Therapy 2017, 11:1593-1603
Published Date: 24 May 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date
Crotti C, Raimondo MG, Becciolini A, Biggioggero M, Favalli EG
Drug Design, Development and Therapy 2017, 11:211-223
Published Date: 13 January 2017